Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

INM stock hub

InMed Pharmaceuticals Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

INMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

INM

In the news

Latest news · INM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-112.6

P25 -106.6P50 -46.9P75 -3.1

ROIC-66.2

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All INM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001728328
Company name	InMed Pharmaceuticals Inc.
Country	Canada
Country code	US
Cusip	457637601
Employees	13
Employees Change	0%
Employees Change Percent	0
Enterprise value	$-1.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA4576377002
Last refreshed	2026-05-10
Market cap	$2.9M
Market cap category	Nano-Cap
Price	$0.65
Price currency	USD
Rev Per Employee	380,202.54x
Sector	Healthcare
Sic	2834
Symbol	INM
Website	https://www.inmedpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-293.25%
FCF yield	-256.99%
P/B ratio	0.31x
P/S ratio	0.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-162.75%
EBITDA Margin	-158.51%
Gross margin	34.53%
Gross Profit	$1.7M
Gross Profit Growth	266.16%
Gross Profit Growth3 Y	174.65%
Net Income	$-8.5M
Net Income Growth Years	0%
Pretax Margin	-158.55%
Profit Margin	-172.17%
Profit Per Employee	$-654,598
ROA	-54.61
Roa5y	-52.04
ROCE	-116.2
ROE	-112.6
Roe5y	-119.9
ROIC	-66.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-52.27%
Cagr1y	-76.27%
Cagr3y	-70.21%
Cagr5y	-79.34%
EPS Growth Quarters	7
EPS Growth Years	6
Revenue Growth	285.22x
Revenue Growth Years	3x
Revenue Growth3 Y	28.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$9.1M
Cash	$5.2M
Current Assets	$6.9M
Current Liabilities	$2.2M
Debt	$420,147
Debt Equity	$0.06
Equity	$6.9M
Interest Coverage	-402.2
Liabilities	$2.2M
Long Term Assets	$2.2M
Long Term Liabilities	$30,766
Net Cash	$4.8M
Net Cash By Market Cap	$165
Net Cash Growth	23.47%
Net Debt Equity	$-0.69
Tangible Book Value	$5.4M
Tangible Book Value Per Share	$1.63
WACC	6.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.11
Net Working Capital	$-134,361
Quick ratio	2.35
Working Capital	$4.7M
Working Capital Turnover	$1.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-365.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.94%
1Y total return	-76.24%
200-day SMA	1.46
3Y total return	-97.36%
50-day SMA	0.75
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.96%
All Time High	32,175
All Time High Change	-100%
All Time High Date	2018-01-08
All Time Low	0.58
All Time Low Change	13.04%
All Time Low Date	2026-03-31
ATR	0.06
Beta	0.57
Beta1y	3.3
Beta2y	3.29
Ch YTD	-38.68
High	0.73
High52	7.98
High52 Date	2025-06-02
High52ch	-91.85%
Low	0.65
Low52	0.58
Low52 Date	2026-03-31
Low52ch	13.04%
Ma50ch	-13.14%
Premarket Change Percent	3.25
Premarket Price	$0.72
Price vs 200-day SMA	-55.54%
RSI	37.35
RSI Monthly	32.08
RSI Weekly	31.8
Sharpe ratio	-0.85x
Sortino ratio	-1.44
Tr YTD	-38.68
Tr1m	-4.47%
Tr1w	-9.03%
Tr3m	-30.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-8M
Operating margin	-162.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,309,343%
Float Percent	74.13%
Shares Insiders	0.11%
Shares Institutions	7.78%
Shares Out	4,464,426
Shares Qo Q	2.37%
Shares Yo Y	365.07%
Short Float	2.89%
Short Ratio	0.55
Short Shares	2.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.6M
Average Volume	29,572.75x
Bv Per Share	2.08
Ch10y	-99.94
Ch1m	-4.47
Ch1w	-9.03
Ch1y	-76.24
Ch3m	-30.87
Ch3y	-97.36
Ch5y	-99.96
Ch6m	-59.38
Change	-6.66%
Change From Open	-9.93
Close	0.7
Days Gap	3.63
Depreciation Amortization	209,664
Dollar Volume	7,883.2
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-8M
EBITDA	$-7.8M
EPS	$-2.53
F Score	2
FCF	$-7.5M
FCF EV Yield	396.99x
FCF Per Share	$-1.67
Financing CF	8,269,048
Fiscal Year End	June
Founded	1,981
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-11
Last Report Date	2026-03-31
Last Split Date	2024-11-14
Last Split Type	Reverse
Last10k Filing Date	2025-09-23
Ma150	1.19
Ma150ch	-45.38%
Ma20	0.72
Ma20ch	-9.93%
Net CF	811,547
Next Earnings Date	2026-05-22
Open	0.72
Optionable	No
Position In Range	0
Post Close	0.65
Postmarket Change Percent	0.09
Postmarket Price	$0.65
Ppne	642,884
Pre Close	0.7
Price Date	2026-05-08
Ptbv Ratio	0.54
Relative Volume	0.41x
Revenue	4,942,633x
SBC By Revenue	2.25x
Share Based Comp	110,970
Tr6m	-59.38%
Volume	12,128

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does INM pay a dividend?

Capital-return profile for this ticker.

Performance

INM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns INM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.8%

Float: +74.1% of shares outstanding

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

INM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.4

Neutral momentum band

Price vs 200-day MA

-55.5%

50/200-day relationship not available

Beta (5Y)

0.57

Less volatile than the market

Sharpe ratio

-0.85

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About INM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INM stock rating?

InMed Pharmaceuticals Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INM analysis?

The full report lives at /stocks/INM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INM?

The latest report frames INM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.